Literature DB >> 4986761

Relative affinity of vancomycin and ristocetin for cell walls and uridine diphosphate-N-acetylmuramyl pentapeptide.

G K Best, M K Grastie, R D McConnell.   

Abstract

A determination of the relative affinity of vancomycin and ristocetin for isolated cell walls and for a peptidoglycan precursor was made. These antibiotics had previously been shown to adsorb to cell walls and to complex with peptides containing a d-alanyl-d-alanine C-terminus. By using (14)C-uridine diphosphate (UDP)-N-acetylmuramyl pentapeptide, it was shown that the complex which is formed between this peptidoglycan precursor and either vancomycin or ristocetin does not preclude adsorption of the antibiotics to cell walls of Micrococcus lysodeikticus. Complex formation between ristocetin and UDP-N-acetylmuramyl pentapeptide was assured by differential absorption spectra. However, when the complex was mixed with cell walls, the antibiotic was sedimented with the walls, and the radioactivity remained in the supernatant solution. This indication that ristocetin and vancomycin have a greater affinity for walls than for UDP-N-acetylmuramyl pentapeptide and that the complex per se does not bind to cell walls suggests that adsorption of these antibiotics to cell walls is probably responsible for the inhibition of peptidoglycan synthesis. This proposal is strengthened by the observation that complexed antibiotic is no less inhibitory for growth of Bacillus subtilis than free vancomycin or ristocetin.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4986761      PMCID: PMC247573          DOI: 10.1128/jb.102.2.476-482.1970

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  12 in total

1.  EFFECT OF VANCOMYCIN ON BACILLUS SUBTILIS.

Authors:  G K BEST; N N DURHAM
Journal:  Arch Biochem Biophys       Date:  1964-04       Impact factor: 4.013

2.  LIPID-PHOSPHOACETYLMURAMYL-PENTAPEPTIDE AND LIPID-PHOSPHODISACCHARIDE-PENTAPEPTIDE: PRESUMED MEMBRANE TRANSPORT INTERMEDIATES IN CELL WALL SYNTHESIS.

Authors:  J S ANDERSON; M MATSUHASHI; M A HASKIN; J L STROMINGER
Journal:  Proc Natl Acad Sci U S A       Date:  1965-04       Impact factor: 11.205

3.  Ristocetins, inhibitors of cell wall synthesis in Staphylococcus aureus.

Authors:  C H WALLAS; J L STROMINGER
Journal:  J Biol Chem       Date:  1963-07       Impact factor: 5.157

4.  Effect of vancomycin on the synthesis of the cell wall mucopeptide of Staphylococcus aureus.

Authors:  D C JORDAN
Journal:  Biochem Biophys Res Commun       Date:  1961-11-20       Impact factor: 3.575

5.  Studies on the mode of action of vancomycin.

Authors:  P E REYNOLDS
Journal:  Biochim Biophys Acta       Date:  1961-09-16

6.  Vancomycin adsorption to Bacillus subtilis cell walls.

Authors:  G K Best; N N Durham
Journal:  Arch Biochem Biophys       Date:  1965-09       Impact factor: 4.013

7.  Adsorption of the ristocetins to Bacillus subtilis cell walls.

Authors:  G K Best; N N Durham
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

8.  Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.

Authors:  H R Perkins
Journal:  Biochem J       Date:  1969-01       Impact factor: 3.857

9.  Reversal of the vancomycin inhibition of peptidoglycan synthesis by cell walls.

Authors:  R K Sinha; R C Neuhaus
Journal:  J Bacteriol       Date:  1968-08       Impact factor: 3.490

View more
  9 in total

1.  Regulation of Cell Division in Escherichia coli: Characterization of Temperature-Sensitive Division Mutants.

Authors:  J N Reeve; D J Groves; D J Clark
Journal:  J Bacteriol       Date:  1970-12       Impact factor: 3.490

2.  The synthesis of peptidoglycan in an autolysin-deficient mutant of Bacillus licheniformis N.C.T.C. 6346 and the effect of beta-lactam antibiotics, bacitracin and vancomycin.

Authors:  J B Ward
Journal:  Biochem J       Date:  1974-07       Impact factor: 3.857

3.  Inhibition of peptidoglycan synthesis by the antibiotic diumycin A.

Authors:  E J Lugtenberg; J A Hellings; G J van de Berg
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

4.  Iodinated vancomycin and mucopeptide biosynthesis by cell-free preparations from Micrococcus lysodeikticus.

Authors:  C Bordet; H R Perkins
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

5.  In vivo and in vitro action of new antibiotics interfering with the utilization of N-acetyl-glucosamine-N-acetyl-muramyl-pentapeptide.

Authors:  E J Lugtenberg; A v Schijndel-van Dam; T H van Bellegem
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

6.  Reversal by a specific peptide (diacetyl-alpha gamma-L-diaminobutyryl-D-alanyl-D-alanine) of vancomycin inhibition in intact bacteria and cell-free preparations.

Authors:  M Nieto; H R Perkins; P E Reynolds
Journal:  Biochem J       Date:  1972-01       Impact factor: 3.857

7.  Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.

Authors:  H J Weiss; J Rogers; H Brand
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Physicochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine.

Authors:  M Nieto; H R Perkins
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

9.  Adaptively evolved human oral actinomyces-sourced defensins show therapeutic potential.

Authors:  Shunyi Zhu; Bin Gao; Yoshitaka Umetsu; Steve Peigneur; Ping Li; Shinya Ohki; Jan Tytgat
Journal:  EMBO Mol Med       Date:  2021-12-20       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.